scholarly journals 2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours

2017 ◽  
Vol 1 ◽  
pp. 28-33 ◽  
Author(s):  
Mette Marie Fode ◽  
Jørgen Baltzer Petersen ◽  
Michael Sørensen ◽  
Marianne Ingerslev Holt ◽  
Susanne Keiding ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Treatment Planning ◽  
Stereotactic Body Radiotherapy ◽  
Functional Treatment ◽  
Emission Tomography ◽  
Liver Tumours ◽  
Positron Emission

The integration of metabolic imaging in stereotactic procedures including radiosurgery: a review

2002 ◽  
Vol 97 ◽  
pp. 542-550 ◽  
Author(s):  
Marc Levivier ◽  
David Wikler ◽  
Nicolas Massager ◽  
Philippe David ◽  
Daniel Devriendt ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Brain Tumors ◽  
Treatment Planning ◽  
Target Volume ◽  
Emission Tomography ◽  
Low Grade ◽  
Content Type ◽  
Positron Emission ◽  
Pet Scanning ◽  
Fine Print

Object. The authors review their experience with the clinical development and routine use of positron emission tomography (PET) during stereotactic procedures, including the use of PET-guided gamma knife radiosurgery (GKS). Methods. Techniques have been developed for the routine use of stereotactic PET, and accumulated experience using PET-guided stereotactic procedures over the past 10 years includes more than 150 stereotactic biopsies, 43 neuronavigation procedures, and 34 cases treated with GKS. Positron emission tomography—guided GKS was performed in 24 patients with primary brain tumors (four pilocytic astrocytomas, five low-grade astrocytomas or oligodendrogliomas, seven anaplastic astrocytomas or ependymomas, five glioblastomas, and three neurocytomas), five patients with metastases (single or multiple lesions), and five patients with pituitary adenomas. Conclusions. Data obtained with PET scanning can be integrated with GKS treatment planning, enabling access to metabolic information with high spatial accuracy. Positron emission tomography data can be successfully combined with magnetic resonance imaging data to provide specific information for defining the target volume for the radiosurgical treatment in patients with recurrent brain tumors, such as glioma, metastasis, and pituitary adenoma. This approach is particularly useful for optimizing target selection for infiltrating or ill-defined brain lesions. The use of PET scanning contributed data in 31 cases (93%) and information that was specifically utilized to adapt the target volume in 25 cases (74%). It would seem that the integration of PET data into GKS treatment planning may represent an important step toward further developments in radiosurgery: this approach provides additional information that may open new perspectives for the optimization of the treatment of brain tumors.

[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning

Lung Cancer ◽  
2008 ◽  
Vol 61 (3) ◽  
pp. 362-368 ◽  
Author(s):  
Laura L. Travaini ◽  
Giuseppe Petralia ◽  
Giuseppe Trifirò ◽  
Laura Ravasi ◽  
Domenico Galetta ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Multidetector Computed Tomography ◽  
Treatment Planning ◽  
Emission Tomography ◽  
Positron Emission ◽  
18F Fdg ◽  
Lesion Treatment
Sign in / Sign up

Export Citation Format

Share Document